Dxcover

OXCan

This company develops blood tests using proteomics and machine learning to enable early cancer detection for healthcare providers and patients.

20/20 BioLabs

This company develops AI-powered blood tests for the early detection and prevention of cancers and chronic diseases for individuals and healthcare providers.

Artera

This company develops artificial intelligence tests that predict cancer outcomes and treatment benefits for clinicians and their patients.

CanSense

This company develops blood-based diagnostic tests using laser spectroscopy and artificial intelligence for early-stage bowel cancer detection for healthcare providers and laboratories.

Oxford Cancer Analytics

The company develops liquid biopsy blood tests using proteomics and machine learning for early lung cancer detection for healthcare providers and screening programmes.

LiquidCell Dx

This company develops blood-based liquid biopsy tests for tumor microenvironment profiling to help pharmaceutical companies and clinical partners predict cancer therapy responses.

Thrive Earlier Detection

This digital health company develops a multi-cancer liquid biopsy test to help healthcare providers detect various cancers through early-stage blood screening.

Oncoliq

This company develops liquid biopsy tests using molecular biology and machine learning for early cancer detection in clinical and screening settings.